Derangement of growth and differentiation control in oncogenesis

被引:28
作者
Corn, PG
El-Deiry, WS
机构
[1] Univ Penn, Howard Hughes Med Inst, Dept Med, Lab Mol Oncol & Cell Cycle Regulat, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA
关键词
D O I
10.1002/bies.10036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human neoplasms develop following the progressive accumulation of genetic and epigenetic alterations to oncogenes and tumor suppressor genes. These alterations confer a growth advantage to the cancer cell, leading to its clonal proliferation, invasion into surrounding tissues, and spread to distant organs. Genes that are altered in neoplasia affect three major biologic pathways that normally regulate cell growth and tissue homeostasis: the cell cycle, apoptosis, and differentiation. While each of these pathways can be defined by a unique set of molecular events, they are not biologically separate. Rather, they function more as an integrated molecular network, and perturbations in one pathway can have profound consequences on another. Insights into what distinguishes the regulation of growth and differentiation in a normal cell versus a cancer cell have led to the development of novel anticancer therapies. (C) 2002 John Wiley Sons, Inc.
引用
收藏
页码:83 / 90
页数:8
相关论文
共 59 条
[1]   Disruption of p53 in human cancer cells alters the responses to therapeutic agents [J].
Bunz, F ;
Hwang, PM ;
Torrance, C ;
Waldman, T ;
Zhang, YG ;
Dillehay, L ;
Williams, J ;
Lengauer, C ;
Kinzler, KW ;
Vogelstein, B .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (03) :263-269
[2]   Requirement for p53 and p21 to sustain G2 arrest after DNA damage [J].
Bunz, F ;
Dutriaux, A ;
Lengauer, C ;
Waldman, T ;
Zhou, S ;
Brown, JP ;
Sedivy, JM ;
Kinzler, KW ;
Vogelstein, B .
SCIENCE, 1998, 282 (5393) :1497-1501
[3]  
Clayman GL, 2000, SEMIN ONCOL, V27, P39
[4]   The kiss of death: promises and failures of death receptors and ligands in cancer therapy [J].
Daniel, PT ;
Wieder, T ;
Sturm, I ;
Schulze-Osthoff, K .
LEUKEMIA, 2001, 15 (07) :1022-1032
[5]   Cellular survival: a play in three Akts [J].
Datta, SR ;
Brunet, A ;
Greenberg, ME .
GENES & DEVELOPMENT, 1999, 13 (22) :2905-2927
[6]   Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery [J].
Datta, SR ;
Dudek, H ;
Tao, X ;
Masters, S ;
Fu, HA ;
Gotoh, Y ;
Greenberg, ME .
CELL, 1997, 91 (02) :231-241
[7]   MICE LACKING P21(C/P1/WAF1) UNDERGO NORMAL DEVELOPMENT, BUT ARE DEFECTIVE IN G1 CHECKPOINT CONTROL [J].
DENG, CX ;
ZHANG, PM ;
HARPER, JW ;
ELLEDGE, SJ ;
LEDER, P .
CELL, 1995, 82 (04) :675-684
[8]  
DeVita VT., 1997, CANC PRINCIPLES PRAC, V5th
[9]   Inhibitory function of p21Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control [J].
Di Cunto, F ;
Topley, G ;
Calautti, E ;
Hsiao, J ;
Ong, L ;
Seth, PK ;
Dotto, GP .
SCIENCE, 1998, 280 (5366) :1069-1072
[10]   Human keratinocytes that express hTERT and also bypass a p16INK4a-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics [J].
Dickson, MA ;
Hahn, WC ;
Ino, Y ;
Ronfard, V ;
Wu, JY ;
Weinberg, RA ;
Louis, DN ;
Li, FP ;
Rheinwald, JG .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (04) :1436-1447